Business Standard

ICICI Venture to sell Vetnex stake to Pfizer for Rs 200 cr

Related News

today announced signing of a definitive share purchase agreement to sell all common shares of RFCL’s Vetnex Animal Health to of world’s largest drug maker Pfizer. The acquisition is expected to close by August 2009, subject to necessary regulatory approvals.

Vetnex Animal Health is a part of RFCL, a significant stake in which was acquired by ICICI Venture from Ranbaxy Laboratories for Rs 125 crore in 2005.

Though ICICI Venture did not disclose much, sources said the deal was worth over Rs 200 crore and that Vetnex had an annual turnover of Rs 100-120 crore. French animal healthcare majors Virbac and Sanofi-Aventis were also in the race, they said. When contacted, RFCL executives declined to comment.

Vetnex is a market leader in poultry, livestock and pet healthcare and is one of the top three players in the Indian animal healthcare market. The company is valued at about Rs 1,400 crore.

RFCL, which operates in chemicals, diagnostics and animal healthcare sectors, had de-merged its animal health division into Vetnex earlier this year.

Read more on:   
|

Read More

Sensex ends at 3-week low; sentiment still weak

The Sensex fell to a three-week low on Monday after disappointing quarterly earnings hit Bank of Baroda and IDFC, while investors continued to book ...

Quick Links

 

Market News

Monte Carlo shares fall 12% on debut

Shares of the company ended at Rs 566.25 compared to the issue price of Rs 645 per share on NSE

Tyre makers agree to help Kerala rubber farmers

Agreement brokered by state govternmet after appeal to major firms for support, will have latter buying from the local market at 25% extra ...

DGFT defers registration of organic textile exports

Industry welcomes the move, says organic products' exports would be possible now

Sebi bars 260 entities from markets

The action comes at a time when the central government has sharpened its focus on unearthing black money stashed abroad

Double digit earnings to cheer markets in FY16

Analysts expect earnings surprises from consumer discretionary, financial and industrial sectors

Back to Top